GLP-1 receptor agonists have the strongest current evidence base, with multiple randomised controlled trials confirming improvements in insulin resistance, weight, and menstrual regularity
However, this is not harmful to health, but merely represents a change in consistency and possibly flavour
Scanners are not always available due to site-specific demands
Who Should Speak With a Healthcare Professional Before Proceeding Anyone with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pancreatitis, gallbladder disease, severe gastrointestinal conditions, pregnancy, breastfeeding, complex medication use, or other relevant medical concerns should discuss GLP-1 therapy with a qualified healthcare professional before considering enrollment in any program
you can cancel anytime